ode Archives - Vascular News

nellix

FDA grants IDE approval to Endologix for EVAS2 study of Nellix

9th October 2017

Endologix has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to commence a confirmatory clinical study (EVAS2) to evaluate the...

Write to us
Editor: Jocelyn Hudson [email protected]
Vascular News Europe Advertising: Rav Pankhania [email protected]
Vascular News North America Advertising: Hannah Shiels [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy